Related Experiment Videos

Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis

S Rantapää-Dahlqvist1, S Wållberg-Jonsson, G Dahlén

  • 1Department of Rheumatology, University Hospital, Umeå, Sweden.

Insights

Rheumatoid arthritis patients show elevated Lipoprotein (a), a risk factor for atherosclerosis. Increased Lp(a) levels correlate with inflammation markers and lower cholesterol, suggesting a complex link between RA and cardiovascular health.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Clinical Biochemistry

Background:

  • Lipoprotein (a) [Lp(a)] is an independent risk factor for atherosclerosis.
  • Rheumatoid arthritis (RA) is a chronic inflammatory disease with potential cardiovascular complications.

Purpose of the Study:

  • To investigate Lp(a) levels in patients with rheumatoid arthritis.
  • To explore the relationship between Lp(a) and disease activity markers in RA.

Main Methods:

  • Studied 93 patients with classical, seropositive rheumatoid arthritis.
  • Measured Lp(a) concentrations and correlated them with orosomucoid, erythrocyte sedimentation rate, and platelet count.
  • Assessed plasma concentrations of cholesterol, HDL-cholesterol, apolipoprotein B, and apolipoprotein AI.

Main Results:

  • Significantly increased Lp(a) levels were observed in RA patients.
  • Elevated Lp(a) correlated with orosomucoid, ESR, and platelet count in patients above 480 mg/l.
  • RA patients exhibited lower plasma cholesterol and HDL-cholesterol compared to controls.
  • Apolipoprotein B and AI showed significant correlations with total cholesterol and HDL-cholesterol, respectively.

Conclusions:

  • Elevated Lp(a) is associated with rheumatoid arthritis, particularly with markers of inflammation.
  • Lower cholesterol and HDL-C levels in RA patients may indicate altered lipid metabolism.
  • Further research is needed to understand the atherogenic risk posed by Lp(a) in RA.

Related Concept Videos